• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Swedish study shows better glycemic control with continuous glucose monitoring

byDaniel FisherandMichael Milligan
January 27, 2017
in Chronic Disease, Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Continuous glucose monitoring (CGM) more effectively lowered HbA1c and standard deviation of blood glucose than conventional therapy.

2. Subjective self-reports of well-being and satisfaction with treatment were increased among patients undergoing CGM than conventional therapy.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Among patients with type 1 diabetes, careful blood glucose monitoring and intermittent insulin administration can achieve relatively tight glycemic control. As opposed to self-monitoring, wherein patients analyze their blood glucose and inject themselves manually with insulin, recent advances in technology have allowed for implantable devices that allow for continuous glucose monitoring (CGM). In this un-blinded, cross-over, randomized controlled trial conducted in Sweden, patients with poor glycemic control were randomized to receive 6 months of either conventional therapy or CGM followed by another 6 month period using the alternative therapy. CGM resulted in a significant decrease in HbA1c as well as standard deviation of blood glucose levels. In addition, patients relying on CGM reported improved levels of overall well-being, treatment satisfaction, and less fear of hypoglycemia. There was no difference in adverse events between groups.

This study suggests that CGM may be superior to conventional therapy for patients with poor glycemic control. However, more studies need to be performed to determine the effects of CGM in a broader patient populations, including those with good glycemic control particular comorbidities. In addition, a cost-benefit analysis between CGM and conventional therapy would greatly aid in the adoption of this technology.

Click to read the study in JAMA

RELATED REPORTS

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

Relevant Reading: Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

In-Depth [randomized controlled trial]: A total of 161 type 1 diabetics with HbA1c above 7.5% were randomly assigned to CGM or conventional therapy for 26 weeks, followed by a 17 week washout period, and then 26 weeks of the alternative therapy. At baseline, all patients used self-injection for insulin, as patients with insulin pumps were excluded. CGM reduced HbA1c by 0.43% (CI95 0.29 to 0.57%) more than conventional therapy. Likewise, CGM resulted in a lower blood glucose standard deviation (68.49 vs 77.34; p < 0.001). Patients who adhered to the CGM monitor protocol at least 70% of the time or more received benefit while those who didn’t were statistically similar to the conventional therapy group. CGM increased overall wellbeing (estimated by the WHO-5 66.1 vs 62.7; p = 0.02), and treatment satisfaction (Diabetes Satisfaction Questionnaire 30.21 vs 26.62; p < 0.001). It also reduced the fear of hypoglycemia (Hypoglycemia Confidence Questionnaire 3.40 vs 3.27; p < 0.001) compared to conventional therapy. No differences were found in the rate of adverse events.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood glucosediabetes mellitus
Previous Post

Bezlotoxumab associated with lower recurrence of C. difficile infection: The MODIFY I and II trials

Next Post

Improved glycemic control with continuous glucose monitoring in American diabetics

RelatedReports

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes
StudyGraphics

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

July 7, 2025
Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss

June 23, 2025
Increased number of daily steps linked with decreased mortality in older women
Chronic Disease

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

May 29, 2025
Glucagon-like Peptide-1 Receptor Agonists and Lower Depression Risk in Older Adults with Diabetes
StudyGraphics

Glucagon-like Peptide-1 Receptor Agonists and Lower Depression Risk in Older Adults with Diabetes

March 13, 2025
Next Post
Pediatric DKA associated with recent acute care visits

Improved glycemic control with continuous glucose monitoring in American diabetics

Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

External compression computed tomography may increase diagnostic accuracy in appendicitis

Researchers validate scoring of postconcussive symptom measure to characterize duration 

Researchers validate scoring of postconcussive symptom measure to characterize duration 

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.